Recommended Atropine Dose for Symptomatic Bradycardia
For adults with symptomatic bradycardia, administer atropine 0.5 to 1 mg IV every 3 to 5 minutes up to a maximum total dose of 3 mg; for children, give 0.02 mg/kg IV (minimum 0.1 mg, maximum 0.5 mg for children or 1.0 mg for adolescents) repeated every 5 minutes up to a total of 1 mg for children or 2 mg for adolescents/adults. 1, 2, 3
Adult Dosing Algorithm
Initial dose: Start with 0.5 to 1 mg IV push 1
- The 2010 International Consensus and AHA guidelines establish this as first-line treatment
- Doses below 0.5 mg may paradoxically worsen bradycardia through a parasympathomimetic effect 4, 5
Repeat dosing: Administer every 3 to 5 minutes as needed 2, 1
- Titrate to achieve minimally effective heart rate (approximately 60 bpm) 4
- Maximum total dose: 3 mg produces complete vagal blockade 1
Special consideration for acute MI: In patients with coronary artery disease or acute myocardial infarction, limit total dose to 0.03 to 0.04 mg/kg 6. Use increments of 0.5 mg cautiously, as excessive tachycardia may worsen ischemia or extend infarct size 4.
Pediatric Dosing Algorithm
Initial dose: 0.02 mg/kg IV/IO 3
- Minimum single dose: 0.1 mg (critical to avoid paradoxical bradycardia)
- Maximum single dose: 0.5 mg for children, 1.0 mg for adolescents
Repeat dosing: Every 5 minutes as needed 3
- Maximum total dose: 1 mg for children, 2 mg for adolescents/adults
Alternative routes when IV/IO unavailable:
- IM: 0.02–0.04 mg/kg 3
- ET (endotracheal): Neonates 0.01–0.03 mg/kg; Children/adolescents 0.03–0.06 mg/kg (2-3× the IV dose) 3
Critical Clinical Caveats
When atropine is likely ineffective or contraindicated:
- Type II second-degree or third-degree AV block with wide QRS escape rhythm (infranodal block) 4, 2
- Post-cardiac transplant patients—atropine may cause paradoxical high-degree AV block due to lack of vagal innervation 1, 2, 1
- Asymptomatic bradycardia does not require treatment 4
Essential first steps in pediatric bradycardia: Oxygenation and ventilation are the primary interventions before any medication 3. Epinephrine (not atropine) is the drug of choice if hypoxia-induced bradycardia persists despite adequate oxygenation and ventilation 3.
Second-line options when atropine fails:
- Epinephrine infusion: 2 to 10 µg/min 1
- Dopamine infusion: 2 to 10 µg/kg/min 1
- Transcutaneous pacing: Consider when full-dose atropine is ineffective, though evidence shows similar efficacy to second-line drugs 1
Common Pitfalls to Avoid
Dosing errors that worsen outcomes:
- Administering <0.5 mg in adults or <0.1 mg in children can paradoxically slow heart rate further 4, 5
- Exceeding 2.5 mg total dose over 2.5 hours in adults increases risk of ventricular tachycardia, ventricular fibrillation, and toxic psychosis 7
- Using higher initial doses (1.0 mg vs. 0.5 mg) correlates with increased adverse effects in acute MI patients 7
Concentration confusion: Atropine comes in different concentrations—calculate dosage carefully, especially in pediatrics where errors can be fatal (10 mg may be lethal in children) 3, 6
Misapplication in wrong bradycardia types: Do not rely on atropine for infranodal blocks (typically anterior MI with wide-complex escape) or severe sinus node dysfunction—proceed directly to pacing 4, 2
The evidence strongly supports these dosing recommendations across multiple high-quality guidelines from the AHA and international consensus statements, with consistent messaging about minimum doses to avoid paradoxical effects and maximum doses to prevent toxicity.